KOTAKMAMC - KOTAKALPHA vs UTKAL SPEC INDUS INDIA L

A side-by-side comparison of KOTAKMAMC - KOTAKALPHA (ALPHA) and UTKAL SPEC INDUS INDIA L (UTKAL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, KOTAKMAMC - KOTAKALPHA leads ALPHA vs UTKAL on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation40
  • Profitability04
  • Growth11
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

ALPHA takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.75
P/E ratio
9.02
0.08
P/B ratio
1.44
0.04%
Dividend yield
0.00%
₹72.31
EPS
₹5.10

Profitability

UTKAL takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-3.38%
Return on equity
28.90%
6.00%
Return on capital
27.01%
14.00%
EBITDA margin
19.46%
9.90%
Net margin
13.21%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-7.64%
Revenue CAGR (3Y)
6.39%
60.16%
Profit CAGR (3Y)
48.93%

Size & financial health

ALPHA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹3.94L Cr
Market cap
₹96 Cr
₹1.00L Cr
Revenue
₹55 Cr
₹9,951 Cr
Net profit
₹7 Cr
1.32
Debt / equity
0.56
KOTAKMAMC - KOTAKALPHA
  • ["Stock is trading at 4.84 times its book value", "Company has low interest coverage ratio.", "Promoter holding has decreased over last quarter: -2.70%", "Company has a low return on equity of 2.41% over last 3 years.", "Company might be capitalizing the interest cost", "Earnings include an other income of Rs.9,193 Cr."]
UTKAL SPEC INDUS INDIA L
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 35.1%"]
  • ["Company has low interest coverage ratio.", "Company might be capitalizing the interest cost", "Working capital days have increased from 102 days to 177 days"]
KOTAKMAMC - KOTAKALPHA full analysis UTKAL SPEC INDUS INDIA L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.